Literature DB >> 16022078

Missing forms and dropout in the TME quality of life substudy.

H Putter1, C A M Marijnen, E Klein Kranenbarg, C J H van de Velde, A M Stiggelbout.   

Abstract

OBJECTIVE: Missing forms may pose problems in health related quality of life (QOL) studies, because the absence of a QOL measure may be related to the patient's health and hence to the patient's QOL itself. Studying patterns of missingness, dropout, and the possible impact of missing data on QOL measures is an important step in reporting outcomes of QOL studies. We study patterns of dropout and evaluate the impact of missing forms in the TME QOL substudy.
METHODS: Patients with rectal cancer, randomized to receive either radiotherapy plus total mesorectal excision (TME) or TME only were included in the TME trial. QOL was evaluated in 1302 Dutch patients, before treatment, and 3, 6, 12, 18 and 24 months after surgery. Here only the visual analogue score (VAS) was studied.
RESULTS: At baseline, differences between VAS scores were found with respect to whether the QOL forms were dated before or after radiotherapy and surgery. Differences were small between different statistical methods accounting for dropout; only a cross-sectional analysis gave biased results.
CONCLUSION: The results of the sensitivity analysis indicated that a linear mixed model analysis is a reliable and attractive approach for this study.

Entities:  

Mesh:

Year:  2005        PMID: 16022078     DOI: 10.1007/s11136-004-0834-7

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  11 in total

1.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

2.  Abdominoperineal resection via total mesorectal excision and autonomic nerve preservation for low rectal cancer.

Authors:  W E Enker; K Havenga; T Polyak; H Thaler; M Cranor
Journal:  World J Surg       Date:  1997-09       Impact factor: 3.352

3.  Comparison of several model-based methods for analysing incomplete quality of life data in cancer clinical trials.

Authors:  D L Fairclough; H F Peterson; D Cella; P Bonomi
Journal:  Stat Med       Date:  1998 Mar 15-Apr 15       Impact factor: 2.373

4.  Mixture models for the joint distribution of repeated measures and event times.

Authors:  J W Hogan; N M Laird
Journal:  Stat Med       Date:  1997 Jan 15-Feb 15       Impact factor: 2.373

5.  Recurrence and survival after total mesorectal excision for rectal cancer.

Authors:  R J Heald; R D Ryall
Journal:  Lancet       Date:  1986-06-28       Impact factor: 79.321

Review 6.  Missing quality of life data in cancer clinical trials: serious problems and challenges.

Authors:  J Bernhard; D F Cella; A S Coates; L Fallowfield; P A Ganz; C M Moinpour; P Mosconi; D Osoba; J Simes; C Hürny
Journal:  Stat Med       Date:  1998 Mar 15-Apr 15       Impact factor: 2.373

Review 7.  Identifying the types of missingness in quality of life data from clinical trials.

Authors:  D Curran; M Bacchi; S F Schmitz; G Molenberghs; R J Sylvester
Journal:  Stat Med       Date:  1998 Mar 15-Apr 15       Impact factor: 2.373

8.  Quality of life in advanced non-small-cell lung cancer: results of a Southwest Oncology Group randomized trial.

Authors:  C M Moinpour; B Lyons; P K Grevstad; L C Lovato; J Crowley; K Czaplicki; Z M Buckner; P A Ganz; K Kelly; D R Gandara
Journal:  Qual Life Res       Date:  2002-03       Impact factor: 4.147

9.  Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133.

Authors:  Patricia A Ganz; Carol M Moinpour; Donna K Pauler; Alice B Kornblith; Ellen R Gaynor; Stanley P Balcerzak; Gretchen S Gatti; Harry P Erba; Sheryl McCoy; Oliver W Press; Richard I Fisher
Journal:  J Clin Oncol       Date:  2003-09-15       Impact factor: 44.544

10.  Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist.

Authors:  J C de Haes; F C van Knippenberg; J P Neijt
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.